ActaOphthalmologica

2014
Circulatinganti-retinalantibodiesinresponsetoanti-angiogenictherapyinexudativeage-relatedmaculardegeneration
1
ska,2Boz_enaRomanowska-Dixon1andMarekSanak2AgnieszkaKubicka-Trzazska,JoannaWilan
12
DepartmentofOphthalmologyandOcularOncology,JagiellonianUniversityMedicalCollege,Krakow,Poland
DivisionofMolecularBiologyandClinicalGenetics,JagiellonianUniversityMedicalCollege,Krakow,Poland
ABSTRACT.
Purpose:Todeterminechangesinanti-retinalantibodies(ARAs)duringanti-VEGFtherapyinpatientswithexudativeage-relatedmaculardegeneration(AMD)andtoassessthecorrelationsbetweenARAsanddiseaseactivity.
Methods:Thestudycomprised98patientstreatedwithintravitrealbev-acizumab.Theophthalmicexaminationincludedbestcorrectedvisualacuity(BCVA),slitlampbiomicroscopy,fundoscopy, uoresceinangiography(FA),andopticalcoherencetomography(OCT).SerumARAslevelswereassessedbyindirectimmuno uorescence(IIF)onnormalmonkeyretinasubstrate.Thesestudieswererepeatedat4weekintervalswithin8monthsofafollow-up.Theseraof50sex-andage-matchedhealthysubjectswereusedascontrols.
Results:Atbaselineexamination,94(95.5%)ofthe98patientswerepositiveforARAs.TheARAstitresweresigni cantlyhigher(p=0.0000)thanincontrols.ApositivecorrelationwasfoundbetweentitresofARAsandthediameterofchoroidalneovascularization(CNV)asmeasuredbyFA(p=0.0000),andcentralretinalthickness(CRT)assessedbyOCT(p=0.0000).ApositivecorrelationwasalsofoundbetweenthediameterofCNV,CRTandthecomplexityofcirculatingARAs.Followingtreatmentallpatientsdemonstratedsigni cantdecreaseinARAslevelsaswellasimprovementofBCVA,reductionofsubretinal uidonOCTanddecreasedleakageonFA.
Conclusion:ChangesinserumARAslevelsoccurredinparallelwithclinicaloutcomesofanti-VEGFtherapy.TreatmentreducedserumlevelsofARAs,withthegreatestreductionoccurringduringthe‘loading’phase.ThisstudydemonstratedthatARAsmayactasaserumbiomarkerofthee cacyofanti-VEGFtherapy.
Keywords:age-relatedmaculardegeneration–anti-retinalautoantibodies–anti-vascularendo-thelialgrowthfactortherapy–bevacizumab
ActaOphthalmol.
ª2014ActaOphthalmologicaScandinavicaFoundation.PublishedbyJohnWiley&SonsLtd
doi:10.1111/aos.12435
Introduction
Age-relatedmaculardegeneration(AMD)istheleadingcauseofblindnessinpeopleovertheageof50yearsindevelopedcountries.Despiteextensive
experimentalandclinicalstudies,itspathogenesisisstillnotfullyunder-stood(Fineetal.2000).However,thereisgrowingevidencethatautoim-munityagainstretinalantigensmight
beinvolvedinthediseaseprocess(Karlstetter&Langmann2012;Yuetal.2012;Whitcupetal.2013).Ithasbeenknownthatoculardiseasesinwhichin ammatoryandautoimmunecomponentsplayanimportantrole,maybeassociatedwiththepresenceofcirculatingARAs.SeveralstudieshaveshownthatARAsarepresentintheseraofpatientswithexudativeAMD(Penfoldetal.1990;Gurneetal.1991;Pateletal.2005;Cherepano etal.2006;Joachimetal.2007;Kubicka- ska2009;Kubicka-Trzazska&WilanTrzazskaetal.2012).Thepreciseroleoftheseantibodiesinthediseaseprocessisunclear.IthasbeensuggestedthatcirculatingARAsmaybeanepiphe-nomenondevelopinginresponsetoretinaldamageoralternatively,theycouldbeinvolvedinthepathogenesisofAMD(Penfoldetal.1990;Gurneetal.1991;Pateletal.2005).
AlthoughthepresenceofserumARAsinpatientswithAMDisthoughttobeasigni cantdiseasemarker,toourknowledgenodataonthebehaviourofcirculatingARAsinresponsetoanti-VEGFtherapyiscur-rentlyavailable.Theaimofthisstudywastoassessthepresenceandpro leofserumARAsinpatientswithexu-dativeAMD,andtoestablishthecorrelationsbetweentheimmuno uo-rescencepatternsandlevelsofARAs,anddiseaseactivity.ThesecondaimwastodeterminechangesinARAsduringintravitrealbevacizumabther-apyandtoassessthecorrelationsbetweencirculatingARAsandthecharacteristicsofdiseaseactivity,
1
Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes...Acute and chronic immunological response to dietary antigen. Gut 1983;24:831...
Circulating Tumor Cells, Disease Progression, and ...response to treatment was determined with the use...Fluorescently labeled monoclonal antibodies specific ...
response against a large variety of self molecules in pSS patients, and, ...the majority of anti-CA antibodies correlated with other circulating autoantibodie...
Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and...Correlations Anti-endothelial with renal injury and circulating markers of endoth...
A response rate of 65% is typically observed at...increase in the number of circulating platelets in...Anti-idiotype antibodies Inhibits complement ...
tested its potential utility in monitoring response to anti-cancer therapy. ...anti-cytokeratin (also known as KERSMCR) antibodies for epithelial cells, ...
Circulating mitochondrial DAMPs cause_基础医学_医药卫生...(MMP)-2) antibodies have no effects (...in response to MTD (Fig. 2e, f) more rapidly...
The role of the circulating CD20+ B cells in ...In addition, the following antibodies were used ...leukemia: an evaluation of response to therapy. ...
Secreted from liver cells, circulating PCSK9 binds...Whether anti-PCSK9 antibodies will reduce the ...and the response to high-dose statin therapy. J...
circulating cancer cells than solid tumors beavoid,...antibodies for cancer diagnosis and therapy. Expert...133 REVIEW acts as an anti-angiogenic cocktail. ...
热门文档